These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy. Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105 [TBL] [Abstract][Full Text] [Related]
25. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304 [TBL] [Abstract][Full Text] [Related]
26. Light and electron microscopic study of cellular proliferation in carcinoid heart disease. Lagace R; Delage C; Boutet M Recent Adv Stud Cardiac Struct Metab; 1975; 10():605-16. PubMed ID: 1209007 [TBL] [Abstract][Full Text] [Related]
27. Carcinoid heart disease. A cardiologist's viewpoint. Lundin L Acta Oncol; 1991; 30(4):499-502. PubMed ID: 1854507 [TBL] [Abstract][Full Text] [Related]
28. [The heart: bystander or participant in neoplasms? The Hedinger syndrome (carcinoid cardiopathy)]. Bostaca I; Ciurea O; Jescu M Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):246-51. PubMed ID: 9455474 [TBL] [Abstract][Full Text] [Related]
29. Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour. Simões-Pereira J; Wang LM; Kardos A; Grossman A Acta Med Port; 2017 May; 30(5):421-425. PubMed ID: 28865508 [TBL] [Abstract][Full Text] [Related]
30. A rare case of intra-cardiac metastasis from an appendiceal carcinoid tumour without liver metastases. Patel S; Heetun M; Gurjar SV; Szakacs S Int J Colorectal Dis; 2009 Aug; 24(8):993-4. PubMed ID: 19387658 [No Abstract] [Full Text] [Related]
31. Monitoring the treatment of carcinoid disease using blood serotonin and plasma 5-hydroxyindoleacetic acid: three case examples. Allen KR; Degg TJ; Anthoney DA; Fitzroy-Smith D Ann Clin Biochem; 2007 May; 44(Pt 3):300-7. PubMed ID: 17456301 [TBL] [Abstract][Full Text] [Related]
34. Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management. Jin C; Sharma AN; Thevakumar B; Majid M; Al Chalaby S; Takahashi N; Tanious A; Arockiam AD; Beri N; Amsterdam EA Cardiology; 2021; 146(1):65-73. PubMed ID: 33070143 [TBL] [Abstract][Full Text] [Related]
35. Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report. Khay K; Arous S; Bentaoune T; Drighil A; Habbal R J Med Case Rep; 2018 Jan; 12(1):23. PubMed ID: 29386066 [TBL] [Abstract][Full Text] [Related]
37. Factors associated with progression of carcinoid heart disease. Møller JE; Connolly HM; Rubin J; Seward JB; Modesto K; Pellikka PA N Engl J Med; 2003 Mar; 348(11):1005-15. PubMed ID: 12637610 [TBL] [Abstract][Full Text] [Related]
38. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Robiolio PA; Rigolin VH; Wilson JS; Harrison JK; Sanders LL; Bashore TM; Feldman JM Circulation; 1995 Aug; 92(4):790-5. PubMed ID: 7641358 [TBL] [Abstract][Full Text] [Related]
39. Quadruple valve involvement in a patient with severe carcinoid heart disease. Chiappini B; Noirhomme P; Verhelst R; El Khoury G J Card Surg; 2006; 21(6):599-600. PubMed ID: 17073966 [TBL] [Abstract][Full Text] [Related]
40. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease. Himelman RB; Schiller NB Am J Cardiol; 1989 Feb; 63(5):347-52. PubMed ID: 2464278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]